Status:
RECRUITING
A Registry of AL Amyloidosis (ReAL)
Lead Sponsor:
Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions:
AL Amyloidosis
Eligibility:
All Genders
18-99 years
Brief Summary
The purpose of this protocol is to generate a large registry of patients with AL amyloidosis.
Detailed Description
Thanks to this registry, it will be possible to collect data at diagnosis and during follow up, in order to be able to describe the natural history of AL amyloidosis in a real-world setting and to def...
Eligibility Criteria
Inclusion
- diagnosis of systemic AL amyloidosis;
- treatment-naïve (pre-treatment data collected at participating center available for retrospective part);
- age ≥18 years;
- ability to understand and willingness to sign an informed consent (patients who already sign informed consent for clinical data to be used in retrospective analyses will be accepted);
- planned (or ongoing) follow-up at participating center.
Exclusion
- non-AL amyloidosis;
- previous treatment for AL amyloidosis.
Key Trial Info
Start Date :
February 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04839003
Start Date
February 27 2020
End Date
May 1 2025
Last Update
November 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy, 27100